Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients - PubMed (original) (raw)

. 2008 Oct;27(10):1243-8.

doi: 10.1007/s10067-008-0893-1. Epub 2008 Apr 22.

Affiliations

• PMID: 18427872
• DOI: 10.1007/s10067-008-0893-1

Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients

Omer Ates et al. Clin Rheumatol. 2008 Oct.

Abstract

Tumor necrosis factor and interleukin 10 have been implicated in the pathogenesis of rheumatoid arthritis (RA). Certain single-nucleotide polymorphisms (SNPs) within the promoter region of the IL-10 and TNF genes have been associated with altered levels of circulating IL10 and TNF. We aimed to explore the association of IL-10 and TNF-alpha polymorphisms in Turkish RA patients. We analyzed the association of TNF-alpha (-308G/A, -238G/A, -376G/A) and IL10 (-1082G/A, -819C/T, -592C/A) polymorphisms in 98 Turkish patients with rheumatoid arthritis and 122 healthy subjects using ARMS-PCR. The correlation of these findings with RF positivity and erosive disease in RA patients was also sought. A significant association was found between having RA and -1082 G allele (p=0.008; OR=1.44, 95% CI 1.11-1.86). There was no association between RA and -819C/T polymorphism. Significant differences were observed in IL10 GCC and ACC haplotypes distribution between RA and control subjects (p=0.006; OR=1.46, 95% CI 1.13-1.89 and p=0.011; OR=1.43, 95% CI 1.09-1.88, respectively). No statistically significant association was found between TNF-alpha 308G/A, -238G/A, -376G/A polymorphisms and RA. No significant association was found between RF positivity and erosive disease and TNF-alpha, IL10 gene polymorphisms. In addition, when combined genotypes were analyzed, no significant difference was found between RA patients and healthy controls. Our findings suggest that IL-10 1082 G/A polymorphism or GCC, ACC haplotypes may be associated with RA in Turkish patients.

PubMed Disclaimer

Similar articles

• Analyses of functional IL10 and TNF-α genotypes in Behçet's syndrome.
  Ateş O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarıkaya A. Ateş O, et al. Mol Biol Rep. 2010 Oct;37(7):3637-41. doi: 10.1007/s11033-010-0015-4. Epub 2010 Feb 27. Mol Biol Rep. 2010. PMID: 20191386
• Tumor necrosis factor (TNF) and TNFR1 polymorphisms are not risk factors for rheumatoid arthritis in a Mexican population.
  Cadena-Sandoval D, Alemán-Ávila I, Barbosa-Cobos RE, Becerril-Mendoza LT, Fragoso JM, Ramírez-Bello J. Cadena-Sandoval D, et al. Mol Biol Rep. 2018 Jun;45(3):227-232. doi: 10.1007/s11033-018-4155-2. Epub 2018 Feb 5. Mol Biol Rep. 2018. PMID: 29404828
• Interleukin-1β, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-α polymorphisms in Tunisian patients with rheumatoid arthritis.
  Lagha A, Zidi S, Stayoussef M, Gazouani E, Kochkar R, Kochbati S, Almawi WY, Yacoubi-Loueslati B. Lagha A, et al. Pathol Biol (Paris). 2015 Sep;63(4-5):179-84. doi: 10.1016/j.patbio.2015.04.004. Epub 2015 May 21. Pathol Biol (Paris). 2015. PMID: 26003199
• Meta-analysis of association between cytokine gene polymorphisms and Behcet's disease risk.
  Liang Y, Xu WD, Zhang M, Qiu LJ, Ni J, Wang XS, Wen PF, Cen H, Leng RX, Pan HF, Ye DQ. Liang Y, et al. Int J Rheum Dis. 2013 Dec;16(6):616-24. doi: 10.1111/1756-185X.12221. Epub 2013 Nov 25. Int J Rheum Dis. 2013. PMID: 24267724 Review.
• Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis.
  Harrison P, Pointon JJ, Chapman K, Roddam A, Wordsworth BP. Harrison P, et al. Rheumatology (Oxford). 2008 Dec;47(12):1768-70. doi: 10.1093/rheumatology/ken374. Epub 2008 Oct 4. Rheumatology (Oxford). 2008. PMID: 18838388 Review.

Cited by

• TNF-α gene polymorphisms and expression.
  El-Tahan RR, Ghoneim AM, El-Mashad N. El-Tahan RR, et al. Springerplus. 2016 Sep 7;5(1):1508. doi: 10.1186/s40064-016-3197-y. eCollection 2016. Springerplus. 2016. PMID: 27652081 Free PMC article. Review.
• Association between tumor necrosis factor polymorphisms and rheumatoid arthritis as well as systemic lupus erythematosus: a meta-analysis.
  Chen L, Huang Z, Liao Y, Yang B, Zhang J. Chen L, et al. Braz J Med Biol Res. 2019 Mar 25;52(3):e7927. doi: 10.1590/1414-431X20187927. Braz J Med Biol Res. 2019. PMID: 30916218 Free PMC article.
• Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis.
  Toonen EJ, Barrera P, Fransen J, de Brouwer AP, Eijsbouts AM, Miossec P, Marotte H, Scheffer H, van Riel PL, Franke B, Coenen MJ. Toonen EJ, et al. Arthritis Res Ther. 2012 Dec 7;14(6):R264. doi: 10.1186/ar4110. Arthritis Res Ther. 2012. PMID: 23217265 Free PMC article.
• Evaluation of genetic polymorphisms in TNF‑α‑308G/A rs1800629 associated with susceptibility and severity of rheumatoid arthritis: A systematic review and meta‑analysis.
  Wang YL, Li XY, Liu L, Li SF, Han PF, Li XD. Wang YL, et al. Exp Ther Med. 2024 May 13;28(1):279. doi: 10.3892/etm.2024.12567. eCollection 2024 Jul. Exp Ther Med. 2024. PMID: 38800041 Free PMC article.
• Tumor necrosis factor alpha induced protein 3, interleukin 10, tumor necrosis factor alpha, and interleukin 17 F genes polymorphisms in Algerian patients with rheumatoid arthritis.
  Benahmed D, Abbadi M, Zaoui D, Hamoudi HA, Boukouaci W, Bouguerra-Aouichat S, Salah SS. Benahmed D, et al. Mol Biol Rep. 2024 Apr 20;51(1):545. doi: 10.1007/s11033-024-09525-2. Mol Biol Rep. 2024. PMID: 38642181

References

1. 1. Hum Immunol. 2001 Jul;62(7):705-13 - PubMed
2. 1. Lancet. 1997 Jan 18;349(9046):170-3 - PubMed
3. 1. Ann Rheum Dis. 2004 Mar;63(3):280-4 - PubMed
4. 1. J Rheumatol. 2001 Aug;28(8):1788-92 - PubMed
5. 1. Tissue Antigens. 1999 Aug;54(2):194-7 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Medical

  • MedlinePlus Health Information